[go: up one dir, main page]

CY1118414T1 - Νεα φαρμακευτικα σκευασματα χρησιμα στη θεραπευτικη αγωγη της αϋπνιας - Google Patents

Νεα φαρμακευτικα σκευασματα χρησιμα στη θεραπευτικη αγωγη της αϋπνιας

Info

Publication number
CY1118414T1
CY1118414T1 CY20171100038T CY171100038T CY1118414T1 CY 1118414 T1 CY1118414 T1 CY 1118414T1 CY 20171100038 T CY20171100038 T CY 20171100038T CY 171100038 T CY171100038 T CY 171100038T CY 1118414 T1 CY1118414 T1 CY 1118414T1
Authority
CY
Cyprus
Prior art keywords
health care
pharmaceutical preparations
new pharmaceutical
drug
preparations useful
Prior art date
Application number
CY20171100038T
Other languages
English (en)
Inventor
Anders Pettersson
Christer Nyström
Susanne Bredenberg
Original Assignee
Orexo Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orexo Ab filed Critical Orexo Ab
Publication of CY1118414T1 publication Critical patent/CY1118414T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Εδώ παρέχεται ένα σκεύασμα κατάλληλο για διαβλεννογόνιο χορήγηση περιλαμβάνον ένα υπνωτικό φάρμακο βραχείας δράσης, το οποίο σκεύασμα παρέχει μια μετρήσιμη συγκέντρωση φαρμάκου στο πλάσμα εντός 10 λεπτών από τη χορήγηση. Το σκεύασμα είναι ικανό παροχής ύπνου κατά παραγγελία, και κατά προτίμηση περιλαμβάνει σωματίδια φαρμάκου, για παράδειγμα ζολπιδέμη ή ένα φαρμακευτικώς αποδεκτό άλας αυτής και έναν παράγοντα προαγωγής της βλεννοπροσκόλλησης, όπως καρβοξυμεθυλοκυτταρινικό νάτριο, τα οποία σωματίδια φαρμάκου και το βλεννοπροσκολλητικό παρουσιάζονται στην επιφάνεια μεγαλύτερων σωματιδίων φορέα.
CY20171100038T 2004-10-27 2017-01-11 Νεα φαρμακευτικα σκευασματα χρησιμα στη θεραπευτικη αγωγη της αϋπνιας CY1118414T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0423800.2A GB0423800D0 (en) 2004-10-27 2004-10-27 New pharmaceutical formulations
PCT/GB2005/004147 WO2006046041A1 (en) 2004-10-27 2005-10-26 New pharmaceutical formulations useful in the treatment of insomnia

Publications (1)

Publication Number Publication Date
CY1118414T1 true CY1118414T1 (el) 2017-06-28

Family

ID=33515600

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20171100038T CY1118414T1 (el) 2004-10-27 2017-01-11 Νεα φαρμακευτικα σκευασματα χρησιμα στη θεραπευτικη αγωγη της αϋπνιας
CY20171101007T CY1119580T1 (el) 2004-10-27 2017-09-26 Νεα φαρμακα σκευασματα χρησιμα στη θεραπευτικη αγωγη της αϋπνιας

Family Applications After (1)

Application Number Title Priority Date Filing Date
CY20171101007T CY1119580T1 (el) 2004-10-27 2017-09-26 Νεα φαρμακα σκευασματα χρησιμα στη θεραπευτικη αγωγη της αϋπνιας

Country Status (13)

Country Link
US (4) US9265720B2 (el)
EP (2) EP1807156B1 (el)
JP (1) JP5064226B2 (el)
CY (2) CY1118414T1 (el)
DK (2) DK2340872T3 (el)
ES (1) ES2610469T3 (el)
GB (1) GB0423800D0 (el)
HU (1) HUE030609T2 (el)
LT (2) LT1807156T (el)
PL (2) PL1807156T3 (el)
PT (2) PT2340872T (el)
SI (2) SI1807156T1 (el)
WO (1) WO2006046041A1 (el)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7658945B2 (en) 2004-02-17 2010-02-09 Transcept Pharmaceuticals, Inc. Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof
US20070287740A1 (en) 2005-05-25 2007-12-13 Transcept Pharmaceuticals, Inc. Compositions and methods of treating middle-of-the night insomnia
US20060276501A1 (en) * 2005-05-25 2006-12-07 Transoral Pharmaceuticals, Inc. Solid compositions for treating middle-of-the-night insomnia
WO2008067549A2 (en) * 2006-11-30 2008-06-05 Transcept Pharmaceuticals, Inc. Stabilized zolpidem pharmaceutical compositions
US20100055181A1 (en) * 2006-12-18 2010-03-04 Lupin Limited Controlled release dosage forms of zolpidem
AU2008251370A1 (en) * 2007-05-10 2008-11-20 Novadel Pharma Inc. Anti-insomnia compositions and methods
CA2728436C (en) * 2008-06-20 2016-07-26 Merck Patent Gmbh Directly compressible and rapidly disintegrating tablet matrix
MX2011012078A (es) * 2009-05-20 2012-03-14 Lingual Consegna Pty Ltd Formulacion terapeutica bucal y/o sublingual.
CN105581991A (zh) * 2015-12-28 2016-05-18 安徽省逸欣铭医药科技有限公司 一种酒石酸唑吡坦舌下片及其制备方法
MX2021003975A (es) 2018-10-08 2021-05-27 Troikaa Pharmaceuticals Ltd Soluciones oromucosas de zolpidem o sales farmaceuticamente aceptables del mismo.
CN111939133A (zh) * 2019-05-16 2020-11-17 鲁南制药集团股份有限公司 一种酒石酸唑吡坦片及其制备方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK152744C (da) 1982-08-13 1988-10-31 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat
SE8800080L (sv) 1988-01-13 1989-07-14 Kabivitrum Ab Laekemedelskomposition
SE8803935L (sv) 1988-10-31 1990-05-01 Kabivitrum Ab Laekemedelskomposition
JPH0665103A (ja) 1992-08-13 1994-03-08 ▲寛▼治 ▲高▼田 向精神薬のための速吸収性舌下投与製剤
US7632517B2 (en) 1997-10-01 2009-12-15 Novadel Pharma Inc. Buccal, polar and non-polar spray containing zolpidem
US6200604B1 (en) 1998-03-27 2001-03-13 Cima Labs Inc. Sublingual buccal effervescent
SE9803240D0 (sv) 1998-09-24 1998-09-24 Diabact Ab A pharmaceutical composition having a rapid action
SE9803239D0 (sv) 1998-09-24 1998-09-24 Diabact Ab Composition for the treatment of acute pain
EP1005863A1 (en) * 1998-12-04 2000-06-07 Synthelabo Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof
WO2001030391A2 (en) 1999-10-27 2001-05-03 Farmarc Nederland Bv Pharmaceutical composition containing midazolam
WO2001078725A2 (en) 2000-04-13 2001-10-25 Synthon B.V. Modified release formulations containing a hypnotic agent
CN1290525A (zh) 2000-10-10 2001-04-11 北京万全阳光医药科技有限公司 冷冻干燥的扎来普隆速溶口服组合物
US20040176359A1 (en) 2001-02-20 2004-09-09 University Of Kentucky Research Foundation Intranasal Benzodiazepine compositions
US20030035839A1 (en) * 2001-05-15 2003-02-20 Peirce Management, Llc Pharmaceutical composition for both intraoral and oral administration
AU2002259241B2 (en) 2001-05-24 2008-09-04 Alexza Pharmaceuticals, Inc. Delivery of sedative-hypnotics through an inhalation route
BR0306843A (pt) * 2002-01-10 2004-12-07 Biovail Lab Inc Formulações sedativas de não-benzodiazepina
AU2003221326A1 (en) * 2002-03-06 2003-09-16 Kyowa Hakko Kogyo Co., Ltd. Tablets quickly disintegrating in oral cavity
JPWO2003103713A1 (ja) * 2002-06-10 2005-10-06 大日本製薬株式会社 速崩壊性錠剤及びその製造方法
ES2199061B1 (es) * 2002-06-10 2005-02-16 Laboratorios Vita, S.A. Comprimidos bucodispersables y procedimiento para su obtencion.
US20050038042A1 (en) * 2002-11-15 2005-02-17 Jenet Codd Modified release composition comprising a short-acting hypnotic for treatment of sleep disorders
CN1418631A (zh) * 2002-12-19 2003-05-21 王登之 治疗失眠的佐匹克隆口腔崩解片及其制备方法
US20040265375A1 (en) 2003-04-16 2004-12-30 Platteeuw Johannes J. Orally disintegrating tablets
AU2004238321B2 (en) * 2003-05-07 2009-08-27 Samyang Biopharmaceuticals Corporation Highly plastic granules for making fast melting tablets
US20050215521A1 (en) * 2003-12-22 2005-09-29 Karim Lalji Modafinil combination therapy for improving sleep quality
US7658945B2 (en) * 2004-02-17 2010-02-09 Transcept Pharmaceuticals, Inc. Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof
BRPI0507733A (pt) 2004-02-17 2007-07-10 Transoral Pharmaceuticals Inc composição para a liberação de um agente hipnótico através da mucosa oral, e, método para tratar um distúrbio do sono em um paciente em necessidade deste
CN1290525C (zh) * 2004-07-13 2006-12-20 赵余庆 一种降血糖的植物提取物及其用途

Also Published As

Publication number Publication date
PT1807156T (pt) 2017-01-19
US20120277261A1 (en) 2012-11-01
EP2340872A1 (en) 2011-07-06
JP2008517988A (ja) 2008-05-29
CY1119580T1 (el) 2018-03-07
EP1807156A1 (en) 2007-07-18
PL1807156T3 (pl) 2017-06-30
US9597281B2 (en) 2017-03-21
LT1807156T (lt) 2016-12-12
PT2340872T (pt) 2017-10-06
US20130230589A1 (en) 2013-09-05
EP1807156B1 (en) 2016-10-12
WO2006046041A1 (en) 2006-05-04
EP2340872B1 (en) 2017-07-05
DK1807156T3 (en) 2017-01-23
US20110268796A1 (en) 2011-11-03
US20080311208A1 (en) 2008-12-18
SI1807156T1 (sl) 2017-01-31
LT2340872T (lt) 2017-09-11
JP5064226B2 (ja) 2012-10-31
HUE030609T2 (en) 2017-05-29
DK2340872T3 (en) 2017-09-18
PL2340872T3 (pl) 2017-12-29
US9265720B2 (en) 2016-02-23
SI2340872T1 (sl) 2017-10-30
ES2610469T3 (es) 2017-04-27
GB0423800D0 (en) 2004-12-01

Similar Documents

Publication Publication Date Title
CY1118414T1 (el) Νεα φαρμακευτικα σκευασματα χρησιμα στη θεραπευτικη αγωγη της αϋπνιας
DE602004017194D1 (de) Pyridylpyrrol-derivate als wirksame kinase-hemmer
ATE405564T1 (de) 1h-imidazoä4,5-cüchinolinderivate zur behandlung von protein kinase-abhängigen krankheiten
BRPI0416801A (pt) derivados de 1h-imidazoquinolina como inibidores de proteìna sinase
HUE040046T2 (hu) Gyógyszerészeti készítmények és hatóanyagok beadására szolgáló eljárások
BRPI0514293A (pt) sais de dicetopiperazina, sais de dicetomorfolina ou sais de dicetodioxano para administração de droga
AR023972A1 (es) Composiciones de medicamentos a base de compuestos anticolinergicamente activos y beta-mimeticos
HUP0402217A2 (hu) Platinaszármazékot tartalmazó gyógyászati készítmények
CY1117667T1 (el) 3,4-διαρυλπυραζολια ως αναστολεις κινασης πρωτεϊνης
CY1114708T1 (el) Παραγωγα πυραζολο-κιναζολινης, διαδικασια για την παρασκευη τους και η χρηση τους ως αναστολεων κινασης
ATE426635T1 (de) Arzneimittelverabreichung
DE602004027932D1 (de) Benzimidazolderivate: herstellung und pharmazeutische anwendungen
JP2006508953A5 (el)
CY1112981T1 (el) Μεθοδος και συνθεση για την αγωγη της ρινιτιδας
CY1118179T1 (el) Φαρμακευτικη συνθεση
HUP0300290A2 (hu) Érkárosító hatású kombinácíós készítmény és terápia
CY1108684T1 (el) Φαρμακευτικες συνθεσεις που περιλαμβανουν ασκορβικο οξυ για τη θεραπεια μυκητοειδων υπερμολυνσεων και μυκητοειδων επανεμφανισεων
BRPI0413438A (pt) derivados de pirimidilpirrol ativos como inibidores de cinase
NO20055891L (no) Kinazolinderivater som aurorakinaseinhibitorer
EA200702522A1 (ru) Система доставки лекарств в полость рта и способы ее применения
ITMI20022777A1 (it) Formulazioni farmaceutiche per ormoni tiroidei e procedimenti per il loro ottenimento.
ATE454891T1 (de) Geschmacksstoffhaltige arzneimittelformulierungen mit verbesserten pharmazeutischen eigenschaften
CY1109215T1 (el) Συστημα χορηγησης οπιοειδους
ITMI20021866A1 (it) Preparazione farmaceutica in forma colloidale utile nella cura delle affezioni cutanee.
AR036518A1 (es) Nuevos medicamentos para la inhalacion